DK0413674T3 - Phosphorylerede glycosidasehæmmerprolægemidler - Google Patents

Phosphorylerede glycosidasehæmmerprolægemidler

Info

Publication number
DK0413674T3
DK0413674T3 DK90870126.1T DK90870126T DK0413674T3 DK 0413674 T3 DK0413674 T3 DK 0413674T3 DK 90870126 T DK90870126 T DK 90870126T DK 0413674 T3 DK0413674 T3 DK 0413674T3
Authority
DK
Denmark
Prior art keywords
phosphorylated
inhibitor drugs
glycosidase inhibitor
glycosidase
therapeutic
Prior art date
Application number
DK90870126.1T
Other languages
Danish (da)
English (en)
Inventor
Peter Richard Scudder
Raymond Allen Dwek
Thomas William Rademacher
Gary Steven Jacob
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of DK0413674T3 publication Critical patent/DK0413674T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK90870126.1T 1989-08-17 1990-08-13 Phosphorylerede glycosidasehæmmerprolægemidler DK0413674T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/394,914 US5043273A (en) 1989-08-17 1989-08-17 Phosphorylated glycosidase inhibitor prodrugs

Publications (1)

Publication Number Publication Date
DK0413674T3 true DK0413674T3 (da) 1996-06-10

Family

ID=23560918

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90870126.1T DK0413674T3 (da) 1989-08-17 1990-08-13 Phosphorylerede glycosidasehæmmerprolægemidler

Country Status (9)

Country Link
US (1) US5043273A (es)
EP (1) EP0413674B1 (es)
JP (1) JPH0791309B2 (es)
AT (1) ATE134639T1 (es)
CA (1) CA2023404C (es)
DE (1) DE69025515T2 (es)
DK (1) DK0413674T3 (es)
ES (1) ES2084019T3 (es)
GR (1) GR3019753T3 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
EP0453692A1 (en) * 1990-04-27 1991-10-30 Merrell Dow Pharmaceuticals Inc. Novel nojirimycin derivatives
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
EP1037636A4 (en) 1997-12-11 2004-08-18 Univ Oxford INHIBITATION OF MEMBRANE-TIED VIRAL REPLICATION
US6465488B1 (en) 1997-12-11 2002-10-15 Chancellor, Masters & Scholars Of The University Of Oxford Inhibition of glycolipid biosynthesis
US6274597B1 (en) * 1998-06-01 2001-08-14 Mount Sinai School Of Medicine Of New York University Method of enhancing lysosomal α-Galactosidase A
US7256005B2 (en) 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
JP2003506406A (ja) 1999-08-10 2003-02-18 ザ・チャンセラー・マスターズ・アンド・スカラーズ・オブ・ザ・ユニバーシティ・オブ・オックスフォード 長鎖ｎ−アルキル化合物およびそのオキサ誘導体
BRPI0613222A2 (pt) 2005-06-08 2010-12-28 Amicus Therapeutic Inc método para purificação de um açúcar bruto contendo nitrogênio e método para purificar d-l-deoxigalactonojirimicina bruta (dgj)
CN101267779A (zh) 2005-07-27 2008-09-17 福罗里达大学研究基金会有限公司 使用热休克治疗眼睛疾病
MY146042A (en) 2005-12-27 2012-06-15 Otsuka Pharma Co Ltd Water-soluble benzoazepine compound and its pharmaceutical composition
JP2009545621A (ja) 2006-08-02 2009-12-24 ユナイテッド セラピューティクス コーポレーション ウィルス感染症のリポソーム処置
CA2666814A1 (en) * 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
EP1995323A1 (en) * 2007-05-24 2008-11-26 Libragen Method for preparing C-6 phosphorylated D-aldohexoses and C-6 phosphorylated D-aldohexose derivatives
EP2282723A2 (en) * 2008-03-26 2011-02-16 University of Oxford Endoplasmic reticulum targeting liposomes
CN106420740A (zh) * 2009-02-23 2017-02-22 伊莫根特病毒学有限责任公司 亚氨基糖以及治疗病毒性疾病的方法
EP2400843B1 (en) * 2009-02-24 2015-11-11 United Therapeutics Corporation Iminosugars and methods of treating arenaviral infections
US8703744B2 (en) * 2009-03-27 2014-04-22 The Chancellor, Masters And Scholars Of The University Of Oxford Cholesterol level lowering liposomes
WO2010135731A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
CA2765086C (en) 2009-06-12 2015-12-15 United Therapeutics Corporation Iminosugars and methods of treating bunyaviral and togaviral diseases
IN2012DN00352A (es) 2009-06-16 2015-08-21 Bikam Pharmaceuticals Inc
ES2485623T3 (es) * 2009-09-04 2014-08-13 United Therapeutics Corporation Procedimiento para el tratamiento de infecciones por poxvirus
CA2772875A1 (en) * 2009-09-04 2011-03-10 United Therapeutics Corporation Methods of treating orthomyxoviral infections
ES2527623T3 (es) * 2009-09-04 2015-01-27 United Therapeutics Corporation Iminoazúcares para su uso en el tratamiento de enfermedades por filovirus
EP2509598A1 (en) 2009-12-07 2012-10-17 The Chancellor, Masters And Scholars Of The University Of Oxford N-substituted deoxynojirimycin compounds for use in inhibiting osteoclastogenesis and/or osteoclast activation
AU2012271728B2 (en) 2011-06-14 2016-10-20 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
AU2012325341B2 (en) 2011-10-19 2017-01-05 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
EP2785346A4 (en) 2011-11-30 2015-04-29 Bikam Pharmaceuticals Inc OPSINBINDING LIGANDS, COMPOSITIONS THEREOF, AND METHOD OF USE THEREOF
AU2012346537A1 (en) 2011-12-01 2014-07-17 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
JP5876856B2 (ja) * 2013-08-02 2016-03-02 中国医学科学院薬物研究所 血糖降下剤を調製するための、桑の枝由来のアルカロイドの有効画分の使用
KR20160055916A (ko) 2013-09-16 2016-05-18 이머전트 바이롤로지 엘엘씨 데옥시노지리마이신 유도체 및 그의 이용 방법
EP3215499B1 (en) 2014-11-05 2021-01-20 Emergent Virology LLC Iminosugars useful for the treatment of viral diseases
WO2017192599A1 (en) 2016-05-02 2017-11-09 Florida State University Research Foundation, Inc. Treatment of zika virus infections using alpha-glucosidase inhibitors
WO2017220298A1 (en) * 2016-06-22 2017-12-28 Unilever N.V. Edible fat-continuous emulsion comprising 1-deoxynojirimycin and lecithin
EP3318277A1 (en) 2016-11-04 2018-05-09 Institut du Cerveau et de la Moelle Epiniere-ICM Inhibitors of glucosylceramide synthase for the treatment of motor neuron diseases
WO2021168483A2 (en) 2020-02-21 2021-08-26 Florida State University Research Foundation, Inc. Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
DE2839309A1 (de) * 1978-09-09 1980-03-27 Bayer Ag 3,4,5-trihydroxypiperidin-derivate
US4847244A (en) * 1985-09-17 1989-07-11 Burroughs Wellcome Co. Treatment of human viral infections
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US4999360A (en) * 1987-12-21 1991-03-12 Monsanto Company Method of inhibiting virus
US4849430A (en) * 1988-03-09 1989-07-18 Monsanto Company Method of inhibiting virus

Also Published As

Publication number Publication date
JPH03118327A (ja) 1991-05-20
ES2084019T3 (es) 1996-05-01
EP0413674B1 (en) 1996-02-28
ATE134639T1 (de) 1996-03-15
JPH0791309B2 (ja) 1995-10-04
EP0413674A2 (en) 1991-02-20
CA2023404A1 (en) 1991-02-18
DE69025515D1 (de) 1996-04-04
DE69025515T2 (de) 1996-10-02
EP0413674A3 (en) 1991-07-17
GR3019753T3 (en) 1996-07-31
US5043273A (en) 1991-08-27
CA2023404C (en) 2001-10-23

Similar Documents

Publication Publication Date Title
DK0413674T3 (da) Phosphorylerede glycosidasehæmmerprolægemidler
ES2038251T3 (es) Un procedimiento para producir un derivado de benzamida.
PT89109A (pt) Metodo para melhorar a funcao cognitiva por administracao de d-ciclosserina e suas pro-drogas
DE69032609D1 (de) Metalloproteinase-Inhibitoren
DE68926727D1 (de) Trizyklische Verbindungen
ES2036562T3 (es) Un procedimiento para produccion de un derivado de pirrolidinamida.
UA6041A1 (uk) СПОСІБ ОДЕРЖАННЯ СПОЛУЧЕНЬ beta-ЛАКТАМА
DE3873007D1 (de) Kathartica.
ES2029842T3 (es) Procedimiento para preparar un derivado de quinolina.
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
GR930100259A (el) Μικροβιακή μέ?οδος παρασκευής μεβινολίνης.
FI893936A0 (fi) Menetelmä terapeuttisesti aktiivisten yhdisteiden valmistamiseksi sekä välituotteita
UA6330A1 (uk) Спосіб одержання похідних бензаміда
FR2445318A1 (fr) Procede de preparation de 1-(3-mercapto-propanoyl)-l-prolines
FR2631570B1 (fr) Procede d'usinage de pignons arbres par rectification des centres
FR2631342B1 (fr) Procede de preparation de cyclodextrines ramifiees par des groupes glucosyle multiples
ATE60779T1 (de) N-glykolylneuraminsaeurederivat.
FR2368495A1 (fr) Procede de preparation d'acides 2-carbamoylphosphiniques n-substitues
IT211843Z2 (it) Produzione di piastre. cilindro per un impianto di
FR2370038A1 (fr) Derives de l'oxime de l'acide 4-(d-3-amino-3-carboxypropoxy) phenylglyoxylique, constituant la chaine laterale de l'antibiotique nocardicine
IT1248667B (it) Purificazione di estraenti costituiti da composti organici del fosforo bidentati
FR2383920A1 (fr) Procede de preparation d'un derive d'acetonitrile et derive obtenu par ce procede
FR2367770A1 (fr) Procede de preparation d'acides alcenylphosphiniques
FR2453159A1 (fr) Procede de preparation de 2-aminopyrazines substituees
ES462071A1 (es) Procedimiento de preparacion de n-2,6-diclorofenil-2-amino- pirimidina.